Lanzhou Univ. KOR compound analogue 4

Lanzhou Univ. KOR compound analogue 4: sourced facts only. name: "Notably, analogue 4 was selected as the final candidate due to its high potency in KOR agonism and minimal sedative effects, making it the most promising drug candidate for the development of efficient and safe antinociceptive and antipruritic therapies." [PMID:41494468]; target: "Notably, analogue 4 was selected as the final candidate due to its high potency in KOR agonism and minimal sedative effects, making it the most promising drug candidate for the development of efficient and safe antinociceptive and antipruritic therapies." [PMID:41494468]; developer: "Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences, and State Key Laboratory of Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, 199 Donggang West Road, Lanzhou 730000, PR China; Department of Nursing, Ningxia Health Vocational and Technical College, Dawukou District, Shizuishan 753000, PR China." [PMID:41494468]